Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00757120 · ClinicalTrials.gov registry record
Biomarkers and Genetic Factors Related to Emphysema
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 145
- Enrollment target
NCT00757120: Completed study, sponsored by Washington University School of Medicine.
NCT00757120 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 145 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00757120 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
Study Summary
Emphysema, a common type of chronic obstructive pulmonary disease (COPD), is a long-term lung disease that is usually caused by cigarette smoking. This study will examine both current smokers and former smokers who have emphysema, as well as current and former smokers who do not have emphysema, to determine if certain factors found in the blood are related to the risk of developing emphysema.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-09 |
What the finished NCT00757120 record still lists
NCT00757120 is an observational study that tracks outcomes without assigning an intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00757120 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00757120 about?
NCT00757120 is a clinical study titled "Biomarkers and Genetic Factors Related to Emphysema". Emphysema, a common type of chronic obstructive pulmonary disease (COPD), is a long-term lung disease that is usually caused by cigarette smoking. This study will examine both current smokers and former smokers who have emphysema, as well as current and former smokers who do not have emphysema, to d...
What is the current status of trial NCT00757120?
This trial is currently completed. The enrollment target is 145 participants. The study started on 2007-10. Estimated completion is 2011-09.
Who is sponsoring clinical trial NCT00757120?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia